The role of fibroblast growth factor 21 in diabetes and its complications: A review from clinical perspective

被引：47

作者：

Liu, Jian-Jun ^{[1
]}

Foo, Joo Pin ^{[2
]}

Liu, Sylvia ^{[1
]}

Lim, Su Chi ^{[3
]}

机构：

[1] Khoo Teck Puat Hosp, Clin Res Unit, Singapore 768828, Singapore

[2] Changi Gen Hosp, Dept Med, Singapore, Singapore

[3] Khoo Teck Puat Hosp, Ctr Diabet, Singapore 768828, Singapore

来源：

DIABETES RESEARCH AND CLINICAL PRACTICE | 2015年 / 108卷 / 03期

关键词：

Fibroblast growth factor 21; Diabetes; Diabetes complications; Diabetes therapy; INCREASES ENERGY-EXPENDITURE; FATTY LIVER-DISEASE; SERUM FGF21 LEVELS; INSULIN SENSITIVITY; METABOLIC SYNDROME; GLUCOSE; OBESITY; EXPRESSION; RESISTANCE; INHIBITION;

D O I：

10.1016/j.diabres.2015.02.032

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Fibroblast growth factor 21 (FGF21) has been well-recognized as a metabolic hormone and a promising target for treatment of metabolic diseases. The level of endogenous FGF21 is elevated in patients with impaired glucose tolerance and progressively increased from patients with overt type 2 diabetes to those with micro-and macro-vascular complications, presumably as a compensation or response to the deterioration of metabolic imbalance. A few exploratory in vivo studies, including a recent clinical trial, showed that exogenous FGF21 mimetics targeting FGF21 signaling can attain beneficial metabolic effects not withstanding the already elevated ambient FGF21 levels. In addition, some clinically available pharmacologic agents such as fenofibrates and metformin may modulate energy and macronutrients metabolism by acting through FGF21. This review mainly focuses on the role of FGF21 in development, progression and treatment of type 2 diabetes from a clinical perspective. (c) 2015 Elsevier Ireland Ltd. All rights reserved.

引用

页码：382 / 389

页数：8

共 66 条

[1] FGF21: The Center of a Transcriptional Nexus in Metabolic Regulation [J].

Adams, A. C. ;

Kharitonenkov, A. .

CURRENT DIABETES REVIEWS, 2012, 8 (04) :285-293

[2] LY2405319, an Engineered FGF21 Variant, Improves the Metabolic Status of Diabetic Monkeys [J].

Adams, Andrew C. ;

Halstead, Carolyn A. ;

Hansen, Barbara C. ;

Irizarry, Armando R. ;

Martin, Jennifer A. ;

Myers, Sharon R. ;

Reynolds, Vincent L. ;

Smith, Holly W. ;

Wroblewski, Victor J. ;

Kharitonenkov, Alexei .

PLOS ONE, 2013, 8 (06)

[3] FGF21 Requires βklotho to Act In Vivo [J].

Adams, Andrew C. ;

Cheng, Christine C. ;

Coskun, Tamer ;

Kharitonenkov, Alexei .

PLOS ONE, 2012, 7 (11)

[4] Serum fibroblast growth factor 21 was elevated in subjects with type 2 diabetes mellitus and was associated with the presence of carotid artery plaques [J].

An, So-Yeon ;

Lee, Min Suk ;

Yi, Sang-A ;

Ha, Eun Suk ;

Han, Seung Jin ;

Kim, Hae Jin ;

Kim, Dae Jung ;

Lee, Kwan-Woo .

DIABETES RESEARCH AND CLINICAL PRACTICE, 2012, 96 (02) :196-203

[5] Circulating Fibroblast Growth Factors as Metabolic Regulators-A Critical Appraisal [J].

Angelin, Bo ;

Larsson, Tobias E. ;

Rudling, Mats .

CELL METABOLISM, 2012, 16 (06) :693-705

[6] Pegylated Fgf21 rapidly normalizes insulin-stimulated glucose utilization in diet-induced insulin resistant mice [J].

Camacho, Raul C. ;

Zafian, Peter T. ;

Achanfuo-Yeboah, Joana ;

Manibusan, Anthony ;

Berger, Joel P. .

EUROPEAN JOURNAL OF PHARMACOLOGY, 2013, 715 (1-3) :41-45

[7] Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance [J].

Chavez, Alberto O. ;

Molina-Carrion, Marjorie ;

Abdul-Ghani, Muhammad A. ;

Folli, Franco ;

DeFronzo, Ralph A. ;

Tripathy, Devjit .

DIABETES CARE, 2009, 32 (08) :1542-1546

[8] High Plasma Level of Fibroblast Growth Factor 21 Is an Independent Predictor of Type 2 Diabetes A 5.4-year population-based prospective study in Chinese subjects [J].

Chen, Cheng ;

Cheung, Bernard M. Y. ;

Tso, Annette W. K. ;

Wang, Yudong ;

Law, Lawrence S. C. ;

Ong, Kwok Leung ;

Wat, Nelson M. S. ;

Xu, Aimin ;

Lam, Karen S. L. .

DIABETES CARE, 2011, 34 (09) :2113-2115

[9] Osteoblast-Targeted Overexpression of PPARγ Inhibited Bone Mass Gain in Male Mice and Accelerated Ovariectomy-Induced Bone Loss in Female Mice [J].

Cho, Sun Wook ;

Yang, Jae-Yeon ;

Her, Sun Ju ;

Choi, Hyung Jin ;

Jung, Ju Yeon ;

Sun, Hyun Jin ;

An, Jee Hyun ;

Cho, Hwa Young ;

Kim, Sang Wan ;

Park, Kyong Soo ;

Kim, Seong Yeon ;

Baek, Wook-Young ;

Kim, Jung-Eun ;

Yim, Mijung ;

Shin, Chan Soo .

JOURNAL OF BONE AND MINERAL RESEARCH, 2011, 26 (08) :1939-1952

[10] Serum Fibroblast Growth Factor-21 Levels Are Associated With Carotid Atherosclerosis Independent of Established Cardiovascular Risk Factors [J].

Chow, Wing Sun ;

Xu, Aimin ;

Woo, Yu Cho ;

Tso, Annette W. K. ;

Cheung, Stephen C. W. ;

Fong, Carol H. Y. ;

Tse, Hung Fat ;

Chau, Ming Tak ;

Cheung, Bernard M. Y. ;

Lam, Karen S. L. .

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2013, 33 (10) :2454-2459

← 1 2 3 4 5 6 7 →